Detalhe da pesquisa
1.
Long-term analysis of the RiBVD phase II trial reveals the unfavorable impact of TP53 mutations and hypoalbuminemia in older adults with mantle cell lymphoma; for the LYSA group.
Haematologica
; 2023 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38031755
2.
Management of bone marrow biopsy related bleeding risks: a retrospective observational study.
J Thromb Thrombolysis
; 54(1): 109-114, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34817787
3.
Challenges for quality and utilization of real-world data for diffuse large B-cell lymphoma in REALYSA, a LYSA cohort.
Blood Adv
; 8(2): 296-308, 2024 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37874913
4.
Salvage therapy with brentuximab-vedotin and bendamustine for patients with R/R PTCL: a retrospective study from the LYSA group.
Blood Adv
; 7(19): 5733-5742, 2023 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36477770
5.
Prognostic Impact of 18F-FDG PET/CT in Patients With Aggressive B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T Cells.
Clin Nucl Med
; 46(8): 627-634, 2021 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34115706
6.
Retrospective multicenter comparative study of the efficacy and safety between R-DHAC and R-DHAOx in diffuse large B-cell lymphoma or transformed follicular or marginal zone B lymphoma into aggressive lymphoma, as a second-line treatment.
Leuk Lymphoma
; 65(2): 270-274, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37966973
7.
[Proteinuria in multiple myeloma: Be careful to iatrogeny]. / Protéinurie dans le myélome : attention à la iatrogénie.
Bull Cancer
; 107(4): 519-520, 2020 Apr.
Artigo
em Francês
| MEDLINE | ID: mdl-32178835
8.
A complex mutational profile and a distinct clonal evolution during NPM1 myeloid sarcoma.
Leuk Lymphoma
; 60(9): 2328-2330, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30707044